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Abstract Mitochondrial damage is one of the prominent 
features of cell death in oxidative stress and related pathological 
conditions. Alteration in membrane lipid composition may be 
responsible for the mitochondrial damage. In this study, we have 
shown that intestinal mitochondria contain an active phospholi-
pase D (PLD) which is activated by oxidants, Ca 2 + or 
polyamines and this results in degradation of phosphatidyletha-
nolamine (PE) and formation of phosphatidic acid (PA). This 
PLD activity is inhibited by nitric oxide (NO) which prevents the 
lipid alteration in mitochondria when exposed to these agents. 
This can be reversed by the NO scavenger, haemoglobin. This 
suggests that alteration of mitochondrial membrane lipid 
composition by activation of PLD in certain pathological 
condition such as oxidative stress may be prevented by the 
simultaneous presence of nitric oxide. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The free radical, nitric oxide has emerged as an important 
signal and effector molecule in mammalian physiology. It has 
been implicated in various normal and pathological condi-
tions, including neurotransmission, vasodilation and inflam-
mat ion [1-3], but can also be cytotoxic, particularly at ele-
vated concentrations [4,5]. The major recognized target of 
N O action is a heme protein, the soluble form of guanylate 
cyclase, whose activity is increased by binding of N O to the 
heme moiety of the enzyme [1-3]. Cellular targets include key 
enzymes in respiration, glycolysis, regulation of iron metabo-
lism, and D N A repair [6-9]. 
With its radical nature, N O ' can rapidly react with oxygen 
and its derivatives to form other potentially toxic radicals. For 
example, peroxynitrite (ONOO - ) is formed in aqueous solu-
tions by an interaction between superoxide anion (02~) and 
NO' . Peroxynitrite decays, once protonated, to the very reac-
tive hydroxyl radical (OH") and nitrogen dioxide radical N0' 2 
[10]. Respiring cells endogenously produce oxygen radicals 
such as 0 2~ and H 2 0 2 that can react with NO" inside the 
cell. One of the sources of these intrinsic radicals is the mito-
chondrial electron transport chain in which 2 - 3 % of the oxy-
gen consumed is leaked in the form of free radicals [11]. Re-
cently we have shown that intestinal mitochondria contain a 
P L D activity which can be activated by oxidants [12], Ca 2 + 
*Corresponding author. Fax: (91) (416) 32035/32054. 
E-mail: balu@gastro.cmc.ernet.in 
Abbreviations: PLD, phospholipase D (EC 3.1.4.4); NO, nitric oxide; 
PA, phosphatidic acid; PE, phosphatidylethanolamine; 0'2~, super-
oxide anion; ONOO' - , peroxynitrite; Hb, haemoglobin; SNP, sodium 
nitroprusside; GSNO, S-nitrosoglutathione 
[13] or polyamines [14] resulting in the formation of phospha-
tidic acid. This PLD preferentially hydrolyses endogenous 
phosphatidylethanolamine and changes in the mitochondrial 
lipid composition brought about by P L D activation may have 
a role in Ca 2 + cycling that is seen during oxidative stress. 
Since N O is known to have both protective and damaging 
effects on cell, the present study looks at the alteration in 
mitochondrial lipids induced by oxidants, Ca 2 + or polyamines 
and the effect of nitric oxide on these lipid changes. 
2. Materials and methods 
2.1. Materials 
Various lipid standards, fluorescamine, HEPES, BSA, spermine, 
xanthine, xanthine oxidase, menadione, haemoglobin, glutathione 
(GSH) and sodium nitroprusside were all obtained from Sigma Chem-
ical Co. All other chemicals used were of analytical grade. Mitochon-
dria were prepared from isolated enterocytes as described [15] and 
suspended in a solution of 250 mM sucrose, 5 mM HEPES pH 7.4 
at a protein concentration of 8-10 mg/ml and used within 2-3 hours. 
2.2. Synthesis of S-nitrosoglutathione 
S-Nitrosoglutathione was prepared according to the method of Ar-
nelle [16]. Briefly, GSNO was synthesized by mixing an equimolar 
concentration of glutathione (100 mM in 250 mM HC1), 0.1 mM 
EDTA (sodium salt), and 100 mM NaN0 2 in water at 25°C for 
6 min. GSNO solution was prepared fresh daily, pH adjusted to 
7.4, and the concentration was confirmed by absorption spectroscopy 
as described [17]. This stock solution was diluted to a final concen-
tration of 1 mM in the reactions described below. 
2.3. Phospholipase D assay 
Mitochondrial PLD was assayed using endogenous phospholipids 
as substrate. Mitochondria (approximately 1 mg protein) in 250 mM 
sucrose, 5 mM HEPES pH 7.4 in a total volume of 1 ml were incu-
bated with the following compounds separately at 37°C for 30 min. 
PLD activity was stimulated by 100 uM Ca2+ or 0.5 mM spermine or 
1 mM xanthine+100 munits xanthine oxidase or 50 mM menadione 
(all final concentration). To check the NO effect, experiments were 
started by exposing the mitochondria to sodium nitroprusside (1 mM) 
or S-nitrosoglutathione (1 mM) as NO donor. In those experiments 
where Ca2+ or spermine were added, 0.3 mM haemoglobin was in-
cluded in the incubations as a scavenger of NO. At the end of incu-
bation, total lipids were extracted by Bligh and Dyer's method [18] 
and PA content analyzed by TLC. Extracted lipids were spotted on 
silica gel G plates impregnated with 0.5 M oxalic acid and separated 
using the solvent system, chloroform:methanol:conc. HC1 (85:13:0.5 
v/v) [19]. PA corresponding to standard was identified by iodine ex-
posure, eluted and quantitated by phosphate estimation after acid 
digestion [20]. Our earlier studies using intestinal mitochondrial 
PLD have shown that this enzyme does not catalyze transphosphati-
dylation in the presence of alcohol [12-14] which is similar to a recent 
report of a yeast PLD unable to catalyze transphosphatidylation [21]. 
2.4. Lipid analysis 
Neutral lipids were separated on silica gel G plates using the solvent 
system hexane:diethyl ether:acetic acid (80:20:1 v/v). Spots corre-
sponding to standard were identified by iodine exposure and eluted. 
Cholesterol [22], diglycerides and triglycerides [23] were estimated as 
described. Free fatty acids were methylated and quantitated by gas 
chromatography after separation on 5% EGSS-X column. Heptade-
canoic acid was used as internal standard. Individual phospholipids 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / / S 0 0 1 4 - 5 7 9 3 ( 9 7 ) 0 0 9 0 3 - 4 
270 
were separated on silica gel H plates using the solvent system chlo-
roform :methanol:acetic acid:water (25:14:4:2 v/v) [24] and quanti-
tated by phosphate estimation after acid hydrolysis. Individual amino-
phospholipids were also quantitated after derivatization with 
fluorescamine and separation on silica gel H plates impregnated 
with 3% magnesium acetate using the solvent system 
chloroform:methanol:NH4OH:water (60:40:5:2 v/v) [25]. Eluted in-
dividual spots were quantitated using Shimadzu SF 5000 spectrofluor-
ometer with excitation at 395 nm and emission at 468 nm. 
2.5. Protein estimation 
Protein was estimated by the method of Lowry et al. [26] using 
bovine serum albumin as standard. 
2.6. Statistical analysis 
Three separate experiments were carried out and results are pre-
sented giving the mean ± S.E.M. Mann Whitney U test was done to 
compare the changes. 
3. Results 
Exposure of the intestinal mitochondria to oxidants, Ca2+ 
or spermine induced alteration in the phospholipid composi-
tion and among the phospholipids only PE level was de-
creased (Fig. 1). There was no change in the level of other 
phospholipids including lysophospholipids (data not shown). 
This decrease in the PE level induced by these agents was 
abolished by the simultaneous presence of NO donor, SNP 
(Fig. 1). Phosphatidic acid, the product of PLD action on 
phospholipids was measured after exposure to these agents. 
As shown in Fig. 2, oxidants, Ca2+ or spermine stimulated the 
formation of PA which was completely inhibited by NO. So-
dium nitroprusside (SNP) which was used as a donor of NO 
was tested at 1 or 5 mM and both concentrations showed 
similar results and hence for all experiments, 1 mM SNP 
was used. A nitroprusside molecule contains five cyanide 
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Fig. 1. Effect of NO on intestinal mitochondrial PLD activity in-
duced by oxidants, spermine and Ca2+ as judged by phosphatidyle-
thanolamine degradation. Experimental conditions are described in 
the text. Each value represents mean ± S.E.M. of three separate esti-
mations. *p<0.05 in treated samples compared to control, p, 0.05 
in treated samples compared to NO incubated samples. 
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Fig. 2. Effect of NO on intestinal mitochondrial PLD activity in-
duced by oxidants, spermine and Ca2+ as assessed by phosphatidic 
acid formation. Experimental conditions are described in the text. 
Each value represents mean ± S.E.M. of three separate estimations. 
*p<0.05 in treated samples compared to control, p, 0.05 in treated 
samples compared to NO incubated samples. 
ions and one nitric oxide surrounding a central iron atom 
[Fe(CN)5NO]
2~ and to rule out the possibility of a cyanide 
effect on the response, mitochondria were pretreated with 
haemoglobin before addition of SNP. This reversed the inhib-
itory effect of SNP as shown in Fig. 3. To further confirm, 
another NO donor, S-nitrosoglutathione was used in presence 
and absence of NO scavenger haemoglobin and the effect of 
Ca2+ and spermine on intestinal PLD activity was measured. 
As shown in Fig. 4, GSNO inhibited the PA formation which 
was reversed by haemoglobin. Incubation of mitochondria 
with oxidants, Ca2+ or spermine did not alter the composition 
of neutral lipids (Table 1). 
4. Discussion 
Oxidative stress is associated with mitochondrial damage 
and altered cellular Ca2+ homeostasis. This process may be 
a consequence of impairment of Ca2+ sequestration by the 
endoplasmic reticulum (ER) and mitochondria which results 
in inability of the cell to maintain its cytosolic free Ca2+ con-
centration within the physiological range [27]. During oxida-
tive stress, Ca2+ overload may result in alteration of cell func-
tion and ultimately in cell death. Oxidative stress is associated 
with non-specific opening of a membrane pore in mitochon-
dria which leads to leakage of many compounds including 
Ca2+. This results in mitochondrial swelling, altered energy 
production, damage to mitochondria and finally cell death. 
During ischemia, mitochondria tries to augment the forma-
tion of ATP by increased Ca2+ uptake [28]. 
Supporting data are available in the literature for both a 
protective and a cytotoxic role for NO in biological systems. 
Nitric oxide has been shown to inhibit mitochondrial function 
of activated macrophages [29,30]. Mitochondria respiration 
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Fig. 3. Effect of haemoglobin (Hb) on sodium nitroprusside (SNP) 
mediated PLD inhibition. Mitochondria were incubated with 100 u,M 
Ca2+ or 0.5 mM spermine (SPM) with 1 mM SNP in absence and 
presence of 0.3 mM haemoglobin. After 30 min incubation, PA was 
analyzed. Each value represents mean ± S.E.M. of three separate es-
timations. *p < 0.05 in Hb treated samples as compared to SNP in-
cubated sample alone. 
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Fig. 4. Effect of S-nitrosoglutathione (GSNO) on enterocyte mito-
chondrial phospholipase D activity and the reversibility of GSNO 
mediated PLD inhibition by haemoglobin. Mitochondria were incu-
bated with 1 mM GSNO in absence and presence of 0.3 mM hae-
moglobin. Each value represents mean ± S.E.M. of three separate es-
timations. *p < 0.05 in Hb treated samples as compared to GSNO 
incubated sample alone. 
was inhibited by NO resulting in reduced ATP synthesis in a 
concentration dependent manner without affecting the activity 
of energy transducing enzymes and the inhibition was signifi-
cantly stronger at physiologically low intracellular oxygen ten-
sion [31]. NO has been shown to inhibit SH- and iron-con-
taining proteins, and electron transport system [32,33]. 
Peroxynitrite which is formed by the reaction of NO with 
0^ ~ may produce oxidant injury itself or through the forma-
tion of a hydroxyl-like radical [34]. Examples of ONOO-in-
duced cell injury include oxidation of cellular thiols, thus de-
pleting cellular GSH and cysteine and exposing cellular 
macromolecules to damage from reactive oxygen species 
[35], inactivation of MnSOD [36] and inactivation of succinate 
dehydrogenase and fumarate reductase in Trypanosoma cruzi, 
thus producing cytotoxicity [37]. NO also increases cytosolic 
concentration of free calcium ion by denergizing mitochondria 
and kills freshly isolated hepatocytes [38,39]. Mitochondrially 
located NO synthase might be involved in the regulation of 
oxidative phosphorylation, because of the ability of NO to 
bind to cytochrome oxidase and inhibit electron transport 
[40]. 
NO appears to be capable of both producing and prevent-
ing oxidant injury in different in vitro and in vivo systems. 
The overall outcome of these two effects in any system may 
depend upon the relative concentrations of individual reactive 
oxygen species [41]. In response to neutrophil mediated injury, 
endothelial cells have been shown to release NO in addition to 
other mediators [42]. Released NO reacts with superoxide to 
Table 1 
Effect of NO on the intestinal mitochondrial neutral lipids 
form peroxynitrite, thus acting as a free radical scavenger and 
blunting oxidant injury [34,35]. In a feline model of myocar-
dial injury NO has been shown to interfere with neutrophil 
adherence to coronary endothelium and attenuate neutrophil 
superoxide production [43]. The protective effects of NO in 
ischemia and reperfusion injury have also been demonstrated 
in other systems [44,45]. NO has also been shown to inhibit 
neutrophil ROS production via a direct effect on NADPH 
oxidase [42] and to function as an antioxidant through the 
formation of NO-iron adducts, thus reducing the availability 
of ferrous iron and thereby ROS production [46]. 
The nitrite production may be a useful index of acute and 
chronic experimental intestinal injury and nitric oxide may 
contribute to the functional repair of the epithelial barrier 
[47]. With respect to intestinal ischemia-reperfusion injury, 
most of the alterations elicited by this process can be induced 
by inhibition of NO synthase in normal rats [48,49]. It has 
also been shown that administration of NO donors provide 
significant protection against dysfunction associated with is-
chemia-reperfusion injury [50]. 
We have recently shown that intestinal mitochondria con-
tain a PLD which can be activated by oxygen free radicals, 
Ca2+ or by poly amines [12-14] and this PLD when stimulated 
by these agents, specifically hydrolyse endogenous PE result-
ing in the generation of PA. The present study has shown that 
the lipid alteration induced by PLD activation by these agents 
can be prevented by the simultaneous presence of NO which 
was reversed by haemoglobin as NO scavenger. To our 
Total cholesterol 
Triglyceride 
Diglyceride 
Free fatty acid 
(nmol/mg protein) 
Control 
(+) 
139 ±11.00 
90 ±6.00 
56 ±4.50 
101 ±11.00 
(") 
136 ±10.00 
87 ±4.50 
57 ±4.00 
103 ±9.30 
X-XO 
(+) 
134 ±10.00 
88 ±7.80 
57 ±4.70 
109 ±9.00 
(") 
132 ±10.40 
84 ±4.70 
55 ± 6.00 
102 ±9.40 
SPM 
(+) 
131 ±9.40 
87 ± 7.40 
54 ±6.00 
107 ±8.70 
(") 
129 ±9.00 
84 ±4.90 
58 ±5.00 
104 ±8.50 
Ca2+ 
(+) 
133 ±8.70 
86 ±5.00 
55 ±4.70 
111 ±8.70 
(") 
130 ±7.90 
84 ±5.80 
57 ±6.00 
102 ±9.50 
Xanthine (X) 1 mM and xanthine oxidase (XO) 100 munits, spermine (SPM) 0.5 mM and Ca2+ 100 u,M were used as final concentration. (+) with 
1 mM SNP, (—) without SNP. Each value represents mean ± S.E.M. of three separate estimations. 
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knowledge, there is no data available on the effect of N O on 
P L D activity. The effect of N O observed here is not due to 
scavenging of free radicals since PLD activation by Ca 2 + or 
polyamine activated PLD was also inhibited by N O . Lipid 
alteration of the mitochondrial membrane is likely to alter 
their function and decrease in PE and increase in PA in mi-
tochondria may have some physiological significance during 
oxidative stress and on Ca 2 + loading and these effects may be 
prevented by N O . This observation supports a possible pro-
tective role for N O in enterocyte mitochondrial damage dur-
ing certain pathological conditions. 
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